FRIEDBERG ALBERT 4
4 · VACCINEX, INC. · Filed Aug 1, 2024
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
FRIEDBERG ALBERT
Director10% Owner
Transactions
- Purchase
Common Stock
2024-07-31$5.74/sh+100,629$577,409→ 663,044 total(indirect: By FCMI Parent Co.) - Purchase
Common Stock
2024-07-31$7.40/sh+16,128$119,283→ 762,415 total(indirect: By FCMI Parent Co.) - Purchase
Common Stock
2024-07-31$6.41/sh+83,243$533,588→ 746,287 total(indirect: By FCMI Parent Co.)
Holdings
- 118,226(indirect: By FCMI Parent Co.)
Warrant (Right to Buy)
Exercise: $14.00From: 2024-02-08Exp: 2029-02-08→ Common Stock (118,226 underlying) - 102,960(indirect: By FCMI Parent Co.)
Warrant (Right to Buy)
Exercise: $7.64From: 2024-03-28Exp: 2029-03-28→ Common Stock (102,960 underlying) - 214,285(indirect: By FCMI Parent Co.)
Warrant (Right to Buy)
Exercise: $14.00From: 2023-10-03Exp: 2028-10-03→ Common Stock (214,285 underlying) - 180(indirect: By Pan Atlantic Holdings Ltd.)
Common Stock
- 2,094
Common Stock
- 16,724(indirect: By Friedberg Global-Macro Hedge Fund Ltd.)
Common Stock
Footnotes (6)
- [F1]Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F2]Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F3]Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F4]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.10 to $6.10, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F5]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.11 to $7.06, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F6]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 to $7.40, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.